Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Filings indexed 916 across all filing types
Latest filing 2020-07-22 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2020-07-22 English
This is with reference to the above mentioned subject, we would like to inform you that the Board of Directors of the Company at its meeting held today i.e. 22nd July, 2020 has considered ....
Regulatory Filings
2020-07-22 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2020-07-17 English
Pursuant to Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we are enclosing herewith Certificate dated 10th July, 2020 ....
Regulatory Filings
2020-07-17 English
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document contains only placeholders for images and no textual content or financial data. It is extremely short (165 characters) and does not provide any report, announcement, or detailed information. Given the lack of content, it cannot be classified as a substantive report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without clear classification.
2020-06-24 English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2020 ,inter alia, to consider and approve Notice is hereby given pursuant to ....
Regulatory Filings
2020-06-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.